Terri Gaskell

Terri Gaskell is driven by a fascination with biological systems, and motivated by a desire to use her knowledge and business experience to accelerate new therapies to address as yet unmet medical needs. Her experience spans pluripotent stem cells, developmental biology, molecular biology and genetics, giving her a broad base to adapt to new areas of research.

Her role at Cell and Gene Therapy Catapult involved overseeing a large and diverse project portfolio, covering every aspect of advanced therapy development, as well as leading and contributing to scientific strategy and taking a key role in licensing negotiations. Leading R&D, licensing and the creation of commercially viable products has been central to her career over the last decade.

She enjoys all aspects of the business, from developing new products to structuring complex projects and their related finances, and bringing scientific rigour to understanding and interpreting the numbers in financial reports, such as quarterly portfolio finances.

Terri believes people are the key to success in any field, and has used her relationship-building and communication skills to build strong teams, inside and outside of those reporting directly to her. This was recognised with an award for displaying the Catapult's key value of "People" in 2018.